Perception vs. Reality

  • YouGov neatly demonstrate how Americans see small subgroups as much larger than they actually are, while large subgroups are systematically underestimated.
  • For example on average people thought that muslims made up 27% of Americans when the true proportion is 1% or that gays and lesbians made up 30%, when the true number is 3%.
  • On the other hand “we find that people underestimate the proportion of American adults who are Christian (estimate: 58%, true: 70%) and the proportion who have at least a high school degree (estimate: 65%, true: 89%).” 
  • Full results here.

Do Founders make good VCs?

  • Nearly 7% of venture capitalists (VCs) were previously founders.
  • This paper, using the VentureSource database, asks if this group is any good at investing?
  • Successful founder-VCs have investment success rates that are 6.5% higher than professional VCs.
  • If you are an unsuccessful founder-VC your investment success is actually 4% lower than professionals.
  • The reason isn’t down to deal quality but value add – “Using an instrumental variables approach to separate unobservable deal quality from value-add, we find that the outperformance of successful founder VCs is consistent with them adding more value post investment.

Mortgage Payments

  • Interest rates are hitting mortgage payments hard.
  • The following graph shows the year-over-year change in principal & interest (P&I) assuming a fixed loan amount since 1977. “
  • Currently P&I is up about 21% year-over-year for a fixed amount (this doesn’t take into account the change in house prices).

Elliott’s Changing Nature

  • If taking a minority public stake and pushing an activist agenda doesn’t work? … why not just take the company private.
  • This is the transition that has been going on at Elliott, the famous hedge fund, over the past several years.
  • Apart from Citrix and Athenahealth (the recent sale made them $5bn of profit) they have done a bunch of other deals (see table).
  • Interestingly, this is all being done out of one fund. The lines between private and public markets continue to blur.

Compounding

  • Compounding is very difficult for human minds to comprehend.
  • As the famous riddle goes:
  • Imagine it’s 10:00 AM on a small pond with a single lily pad. If the number of lily pads on the pond doubles every minute, and the entire pond is full of lily pads by 11:00 AM, at what time is the pond half full of lily pads?
  • The answer is here and many get this wrong.
  • Morgen Housel brings this up in his conversation with Tim Ferriss (worth a full listen) when he talks about Warren Buffett who’s real talent, when compared to other greats like Jim Simons, was not the level of investment returns (Simons’ are much higher) but their longevity. As he says “if Buffett had retired at age 60, like a normal person might, no one would’ve ever heard of him” (transcript).

History of Semiconductor Cycles

  • Semis are notoriously cyclical and it pays to study historic cycles.
  • This is exactly what this post does – looking at the 1980s and trying to draw lessons about the industry.
  • A key thread is probably how strong domestic support tips a geopolitical in-balance (Japan vs. US then). Something eerily similar is happening today.

Ukraine

  • This is a very useful resource for tracking what is going on in the Ukraine war.
  • Produced by The Institute for Study of War (ISW) it is a daily assessment (see under “Latest”, example here) of the situation on the ground along with a useful map (pictured).
  • Here is a video that time lapses all the maps since the invasion began.
  • This Substack (written by Lawrence Freedman, Emeritus Professor of War Studies at King’s College) provides some very good analysis of the meta situation.
  • One angle that is key to watch for second order thinking is China. This was a really great piece to understand the China angle as was this (arguing that perhaps this crisis could push China back to collective leadership).
  • (h/t The Browser).

Biotech Bearishness

  • Fundamentals have been bad in biotech land, something that is reflecting in share prices and IPO performance (XBI has halved since peak).
  • Positive news flow among small and mid-cap biotechs, which hit 60% in 2020, has just fallen below 30%.
  • “But it’s not just small caps, it’s across the sector: Jefferies’ Michael Yee said of 45 major clinical readouts from large and small players, only 20% were positive.”
  • Clinical holds have also spiked – 2022 is off to a bad start (13 holds in 8 weeks) and could surpass the already bad 2021 (>50 vs. 30 average historically.
  • The full article offers some explanations of what is going on.
WordPress Cookie Notice by Real Cookie Banner